ISSN: 2167-0846

Журнал боли и облегчения

Открытый доступ

Наша группа организует более 3000 глобальных конференций Ежегодные мероприятия в США, Европе и США. Азия при поддержке еще 1000 научных обществ и публикует более 700 Открытого доступа Журналы, в которых представлены более 50 000 выдающихся деятелей, авторитетных учёных, входящих в редколлегии.

 

Журналы открытого доступа набирают больше читателей и цитируемости
700 журналов и 15 000 000 читателей Каждый журнал получает более 25 000 читателей

Индексировано в
  • Индекс Коперника
  • Google Scholar
  • Открыть J-ворота
  • Генамика ЖурналSeek
  • Космос ЕСЛИ
  • РефСик
  • Университет Хамдарда
  • ЭБСКО, Аризона
  • OCLC- WorldCat
  • Публикации
  • Женевский фонд медицинского образования и исследований
  • Евро Паб
  • ICMJE
Поделиться этой страницей

Абстрактный

High-frequency Spinal Cord Stimulation as a Palliative Treatment for Patients with Low Back and Lower Extremity Radiated Chronic Pain

Alcobia-Diaz B, Luque-Perez R, Urda Martínez-Aedo A, Noriega-Bastos M, Domínguez-Esteban I and Marco Martínez F

Introduction: Since "Gate Control" theory was published, Spinal Cord Stimulation (SCS) has been used in palliative management of Low-back Pain (LBP) and lower extremity Radiated Pain (RP) and functionality in patients with Lumbar Stenosis (LS), Degenerative Scoliosis (DS) or Failed Back Surgery Syndrome (FBSS). Our aim is to describe our experience with High Frequency Spinal Cord Stimulation (HF-SCS).
Methods: Descriptive, retrospective study (n=30) between 2014-2017 with HF-SCS due to intractable LBP and RP. Mean age was 69 (45-87), mean Comorbidity Charlson Index (CCI) was 6; 80% female with minimum follow up of 12 months. Items reviewed were time to implantation, VAS for LBP and RP and Owestry disability index (ODI), improvement in hungry, emotional status or sleeping; and personal satisfaction. Complications related to procedure were also recorded.
Results: HF-SCS was indicated in 25% patients because of LBP and LERP secondary to LS or not operable DS. Median time to surgery was 3 years (ICR 1-6). Pre and post-surgery mean (SD) values were VAS-LBP 8.63 (1.09) 4.43 (2.5); VAS-LERP 7.03 (2.84) 4.77 (2.49); and ODI 67.2 (11.9) 48.33 (16.93). All of these were statistically significant (p<0.01); 60% improved in sleeping and mood. No patient presented lower limbs paraesthesia, but 13% had electrodes mobilization. 73% were finally satisfied with treatment received.
Conclusion: HF-SCS use for refractory LB and RP could be an effective tool to improve patient pain and functionality with high satisfaction. Especially in those who are not candidates for corrective surgery because of their age or comorbidities.